highly significantp < 0.01
Additionally, as the dosage of the combined drug increased in the GBE (300, 600) group, the area of hepatic fat deposition experienced a highly significant reduction ( p < 0.01).
Additionally, as the dosage of the combined drug increased in the GBE (300, 600) group, the area of hepatic fat deposition experienced a highly significant reduction ( p < 0.01).